Alexi Vasbinder
Impact in
- Nephrology top 10%
- Parathyroid Disorders and Treatments
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 16
- Heart Failure Treatment and Management 5
- Cardiovascular Function and Risk Factors 4
- Oncology 16
- Cancer survivorship and care 7
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Richard K. Cheng (20 shared papers)Douglas Leedy (6 shared papers)Wayne C. Levy (4 shared papers)Mathew S. Maurer (2 shared papers)Jeffeny De Los Santos (1 shared paper)Sergio Teruya (1 shared paper)Kerryn W. Reding (18 shared papers)Salim S. Hayek (13 shared papers)
- Journals
- JACC CardioOncology (6 papers)Journal of the American Heart Association (3 papers)Journal of Clinical Oncology (3 papers)Current Cardiology Reports (2 papers)Circulation (2 papers)
- Partner nations
- United StatesSaudi ArabiaSpain
In The Last Decade
Alexi Vasbinder
33 papers receiving 272 citations
Peers
Comparison fields: 5 of 59
- Nephrology 59
- Cardiology and Cardiovascular Medicine 121
- Oncology 97
- Molecular Biology 127
- Geriatrics and Gerontology 5
Countries citing papers authored by Alexi Vasbinder
This map shows the geographic impact of Alexi Vasbinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexi Vasbinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexi Vasbinder more than expected).
Fields of papers citing papers by Alexi Vasbinder
This network shows the impact of papers produced by Alexi Vasbinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexi Vasbinder. The network helps show where Alexi Vasbinder may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexi Vasbinder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 67 | |
| 2 | 2021 | 34 | |
| 3 | 2021 | 29 | |
| 4 | 2022 | 23 | |
| 5 | 2022 | 20 | |
| 6 | 2023 | 12 | |
| 7 | 2024 | 12 | |
| 8 | 2020 | 10 | |
| 9 | 2022 | 9 | |
| 10 | 2025 | 9 | |
| 11 | 2022 | 8 | |
| 12 | 2023 | 7 | |
| 13 | 2024 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2020 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2024 | 3 |
About Alexi Vasbinder
Alexi Vasbinder is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Physiology, having authored 39 papers that have together received 286 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (16 papers), Cancer survivorship and care (7 papers), Heart Failure Treatment and Management (5 papers), Cancer-related cognitive impairment studies (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Parathyroid Disorders and Treatments (3 papers). The work is most often cited by research in Nephrology (59 citations), Cardiology and Cardiovascular Medicine (121 citations), Oncology (97 citations), Molecular Biology (127 citations) and Geriatrics and Gerontology (5 citations). Alexi Vasbinder has collaborated with scholars based in United States, Saudi Arabia and Spain. Frequent co-authors include Richard K. Cheng, Douglas Leedy, Wayne C. Levy, Mathew S. Maurer, Jeffeny De Los Santos, Sergio Teruya, Kerryn W. Reding, Salim S. Hayek, Ana Barac and Aladdin H. Shadyab. Their work appears in journals such as JACC CardioOncology, Journal of the American Heart Association, Journal of Clinical Oncology, Current Cardiology Reports and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.